A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older

Clinical trial NCT06134804 · COMPLETED

Trial details

NCT number

NCT06134804

Sponsor

Janssen Research & Development, LLC

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2023-10-24

Primary completion

2024-02-19

Enrollment

959

View on ClinicalTrials.gov